President Donald Trump told a meeting of pharmaceutical company leaders at the White House on Tuesday that, while there have been many successes in drug development, the pricing has been ''astronomical'' and must come down. Rough Cut (no reporter narration).
ROUGH CUT (NO REPORTER NARRATION) STORY: U.S. President Trump convened a meeting of pharmaceutical company leaders in an effort, he said, to get the price of drugs "way down." Trump has accused drugmakers of "getting away with murder" on prices. Trump and the Republican-majority Congress, as well as raising concerns over medicine prices, have also begun rolling back former President Barack Obama's signature healthcare legislation. Trump spooked investors in the pharmaceuticals and biotech sectors by saying on January 11, while president-elect, that drug companies were "getting away with murder" on what they charged the government for medicine and that he would do something about it. That prompted PhRMA, the industry's largest lobbying group, to unveil a new TV marketing campaign last week, called "Go Boldly," to improve its image by focusing attention on strides in research. Company executives, meanwhile, have tried to tread a careful line in defending their industry while expressing optimism that the United States would continue to reward scientific advances.